IL105223A0 - Cyclohexane-ylidenes and pharmaceutical compositions containing them - Google Patents

Cyclohexane-ylidenes and pharmaceutical compositions containing them

Info

Publication number
IL105223A0
IL105223A0 IL10522393A IL10522393A IL105223A0 IL 105223 A0 IL105223 A0 IL 105223A0 IL 10522393 A IL10522393 A IL 10522393A IL 10522393 A IL10522393 A IL 10522393A IL 105223 A0 IL105223 A0 IL 105223A0
Authority
IL
Israel
Prior art keywords
ylidenes
cyclohexane
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL10522393A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL105223A0 publication Critical patent/IL105223A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
IL10522393A 1992-04-02 1993-03-30 Cyclohexane-ylidenes and pharmaceutical compositions containing them IL105223A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86211292A 1992-04-02 1992-04-02
US96876092A 1992-10-30 1992-10-30
PCT/US1993/001988 WO1993019747A1 (fr) 1992-04-02 1993-03-05 Composes destines a traiter les maladies allergiques et inflammatoires

Publications (1)

Publication Number Publication Date
IL105223A0 true IL105223A0 (en) 1994-08-26

Family

ID=27127669

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10522393A IL105223A0 (en) 1992-04-02 1993-03-30 Cyclohexane-ylidenes and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US5602173A (fr)
EP (1) EP0634930A4 (fr)
JP (1) JP3195352B2 (fr)
CN (1) CN1094711A (fr)
AU (1) AU3738293A (fr)
IL (1) IL105223A0 (fr)
MA (1) MA22923A1 (fr)
MX (1) MX9301903A (fr)
SI (1) SI9300170A (fr)
WO (1) WO1993019747A1 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0633776T3 (da) * 1992-04-02 2001-08-27 Smithkline Beecham Corp Forbindelser, som kan anvendes til behandling af allergiske og inflammatoriske sygdomme
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5646156A (en) * 1994-04-25 1997-07-08 Merck & Co., Inc. Inhibition of eosinophil activation through A3 adenosine receptor antagonism
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US6066641A (en) * 1994-12-13 2000-05-23 Euro-Celtique S.A. Aryl thioxanthines
JPH10511662A (ja) * 1994-12-23 1998-11-10 スミスクライン・ビーチャム・コーポレイション １，４，４−（三置換）シクロヘキサン二量体および関連化合物
EP0799185A4 (fr) * 1994-12-23 1998-03-25 Smithkline Beecham Corp Dimeres 1,3,3-(trisubstitues)cyclohexane et composes apparentes
JPH10511659A (ja) * 1994-12-23 1998-11-10 スミスクライン・ビーチャム・コーポレイション １，４，４−（三置換）シクロヘキサン単量体および関連する化合物
ES2191754T3 (es) * 1995-05-18 2003-09-16 Altana Pharma Ag Fenil-dihidrobenzofuranos.
WO1996036626A1 (fr) * 1995-05-18 1996-11-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Dihydrobenzofuranes de cyclohexyle
US6268373B1 (en) 1995-06-07 2001-07-31 Euro-Celtique S.A. Trisubstituted thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US5891883A (en) * 1995-12-21 1999-04-06 Smithkline Beecham Corporation 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
EP1524268B1 (fr) * 1997-02-12 2007-01-17 Smithkline Beecham Corporation Composés et procédé de préparation d'acides 4-phényle-4-cyanocyclohexanoiques substitués
DK1295869T3 (da) * 1997-02-12 2005-11-21 Smithkline Beecham Corp Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
AR012550A1 (es) * 1997-02-12 2000-11-08 Smithkline Beecham Corp Metodo para preparar acidos 4-fenil-4-ciano-ciclohexanoicos sustituidos y compuestos intermediarios
US20040220424A1 (en) * 1999-08-06 2004-11-04 Smithkline Beecham Corporation Process for preparing acids via alpha-chloroepoxy esters
UY26268A1 (es) * 1999-08-06 2001-01-31 Smithkline Beecham Corp Procedimiento para preparar acidos a traves de alfa-cloroep xi- esteres ley 17164 art 127
EP1212089B1 (fr) 1999-08-21 2006-03-22 ALTANA Pharma AG Combinaison synergetique de roflumilast et salmeterol
CA2402384A1 (fr) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Inhibiteurs benzyles de pde4
BR0113167A (pt) 2000-08-11 2003-06-24 Ono Pharmaceutical Co Derivados de piperidina e agente que compreende o derivado como ingrediente ativo
TWI305530B (en) 2002-02-08 2009-01-21 Ono Pharmaceutical Co Piperidine derivative compound and pharmaceuticals containing same as active ingredient
JPWO2003066591A1 (ja) * 2002-02-08 2005-05-26 小野薬品工業株式会社 ピペリジン誘導体化合物およびその化合物を有効成分として含有する薬剤
AU2003253130A1 (en) * 2002-08-19 2004-03-03 Glenmark Pharmaceuticals Limited Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders
EA010408B1 (ru) 2002-10-23 2008-08-29 Гленмарк Фармасьютикалс Лтд. Трициклические соединения для лечения воспалительных и аллергических нарушений, способы их приготовления и содержащие их фармацевтические составы
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
OA13154A (en) 2003-04-11 2006-12-13 Glenmark Pharmaceuticals Sa Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them.
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1799632A2 (fr) 2004-10-13 2007-06-27 Glenmark Pharmaceuticals S.A. Procede de preparation de n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
CN101124229B (zh) 2004-12-17 2012-07-18 格兰马克药品股份有限公司 用于治疗炎性和过敏性障碍的新杂环化合物
AP2334A (en) 2004-12-17 2011-12-06 Glenmark Pharmaceuticals Sa Novel heterocyclic compounds useful for the treatment of inflamatory and allergic disorders.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (fr) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
EP3241839B1 (fr) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (fr) 2019-05-21 2020-11-26 Ardelyx, Inc. Combinaison pour baisser le phosphate sérique chez un patient

Also Published As

Publication number Publication date
EP0634930A1 (fr) 1995-01-25
WO1993019747A1 (fr) 1993-10-14
US5602173A (en) 1997-02-11
JP3195352B2 (ja) 2001-08-06
EP0634930A4 (en) 1995-02-22
AU3738293A (en) 1993-11-08
SI9300170A (sl) 1993-12-31
MX9301903A (es) 1994-08-31
MA22923A1 (fr) 1994-04-01
JPH07508261A (ja) 1995-09-14
CN1094711A (zh) 1994-11-09

Similar Documents

Publication Publication Date Title
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL105221A0 (en) Cyclohexane derivatives and pharmaceutical compositions containing them
IL95351A0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
IL106553A0 (en) Substituted imidazoles and pharmaceutical compositions containing them
GB9319500D0 (en) Pharmaceutical composition
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
GB2272375B (en) Pharmaceutical composition
HU9303304D0 (en) Thienyl-pyrrolidinyl-carbapenem-derivatives providing antibiotic effect and pharmaceutical compositions containing it
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
IL105551A0 (en) Quinazolines and pharmaceutical compositions containing them
IL107611A0 (en) Steroid compounds and pharmaceutical compositions containing them
IL104944A0 (en) Anti-tumor agents and pharmaceutical compositions containing the same
GB9221707D0 (en) Pharmaceutical composition
ZA944769B (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
IL106352A0 (en) Pyridoindolo-benzodiazepines and pharmaceutical compositions containing them
IL106080A0 (en) Pharmaceutical compositions containing amidines and novel amidines
IL103132A0 (en) Digitalis-like compounds and pharmaceutical compositions containing them